FDA NDC Directory · JSON-LD · Markdown

FUROSEMIDE

NDC 51662-1336 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerHF Acquisition Co LLC, DBA HealthFirst
Marketing categoryNew Drug Application (innovator) · App NDA018667
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsFUROSEMIDE (10 mg/mL)
Marketing started20181126
Package count2

External sources

Source: openFDA. Public-domain (CC0).